Table TDI-21. Gender ratio by primary drug of clients entering treatment, 2008 or most recent year available [see all tables in this series...]

Part (i) New outpatient clients, ratio of males to females by country and primary drug

Country		Opioids	Cocaine	Stimulants	Hypnotics and sedatives	Hallucinogens	Volatile substances	Cannabis	Other drugs	Gender and drug known
Belgium	(1)	3.8	5.2	3.1	3.0	2.0		6.9		505
Bulgaria		5.0		1.0	0.0			3.0		220
Czech Republic		2.5	3.0	1.2	0.5	4.0	7.0	2.4	0.3	993
Denmark		2.9	3.8	2.2	1.0			3.5	1.1	1362
Germany		3.2	5.4	2.6	0.7	2.3	1.1	6.3	2.8	12894
Estonia	(2)	3.0		1.0			0.0			176
Ireland		2.1	7.0	2.8	1.3		0.9	5.3	1.0	2106
Greece	(3)	7.0	6.1		2.3			6.4		1209
Spain	(4)	5.1	5.6	3.8	1.2	4.0	5.2	5.4	1.9	22988
France		3.7	3.1	3.7	1.2	3.8	2.7	6.7	4.3	8067
Italy	(5)	6.0	6.1	6.2	6.1	6.0		6.0	6.4	34334
Cyprus		4.9	8.3		0.0			11.9		258
Latvia		3.8		3.2	1.9		26.0	14.3	3.5	624
Lithuania		3.3		12.0	0.3				3.2	272
Luxembourg
Hungary		4.0	7.5	3.3	0.9	4.0	4.5	8.9	1.5	1245
Malta	(6)	4.0	6.0	2.2			1.0	7.5		358
Netherlands	(7)	3.5	4.5	2.8	0.9	2.1	1.5	3.5	0.8	6547
Austria		2.2	4.9	2.2	1.4		1.0	4.7	1.0	1339
Poland
Portugal		7.0	4.7	11.0	0.9	4.0		6.0	4.5	4784
Romania		7.4	6.0	11.0				12.5		409
Slovenia		3.6	3.0	0.0	0.0			3.5		273
Slovakia	(8)	2.2	5.0	3.1	1.0			7.5		356
Finland		1.4	0.0	1.0	5.7			2.3	0.3	214
Sweden		1.0	7.5	1.7	0.7		0.3	4.3	2.5	726
United Kingdom		2.7	3.3	1.5	1.1	1.9	1.9	3.2	2.7	43136
Croatia		4.4	3.6	5.4	2.0		1.0	9.8	11.0	1430
Turkey
Norway
Total		3.9	4.8	2.1	1.1	3.9	2.8	4.7	3.4	4.0
Total base		53114	36730	6945	2785	978	469	43874	1930	146825

Notes:

 Empty cells correspond to instances where no female case has been reported. In such instances, the number of male cases also tends to be small or zero, but if the number of male clients exceeds 5 units, then a specific note is presented. Ratios equal to zero correspond to instances where no male cases have been reported while female cases have been reported. In such instances, the number of female cases tends also to be small, but if the number of female client exceeds 5 units, then a specific note is presented. 

 (1) Last available data refer to 2005 and to outpatient centres and low-threshold agencies (aggregated data). Brussels Capital Region is not covered. 

 (2) For Cannabis 6 males have been reported. 

 (3) For Stimulants 11 males have been reported. 

 (4) Data refer to 2007 and to outpatient and prison centres (aggregated data). 

 (5) For Volatile substances 50 males have been reported.                     

 (6) Last data available refer to 2006 and to outpatient, inpatient treatment centres, low-threshold agencies, units in prison and dual-diagnosis unit of psychiatric hospital (aggregated data). 

 (7) Data refer to outpatient, inpatient and low-threshold agencies (aggregated data). 

 (8) For Volatile substances 13 males have been reported.                     

 See also 'General notes for interpreting data' on the Explanatory notes and help page. 

Sources:

 Reitox national reports 2009 — TDI — outpatient treatment centres. 

• Download this data in Excel (.xls) format

(see the help page for information about formats etc.)